Attorney General Todd Rokita is calling on Hoosiers to check their eligibility for compensation for certain generic drug purchases after the U.S. District Court for the District of Connecticut granted preliminary approval of a plan to distribute settlement funds from manufacturers accused of conspiring to inflate generic drug prices.
Attorney General Rokita’s office and a coalition of 47 other states and territories previously announced settlements with Glenmark, Lannett, Bausch, Apotex, Heritage, and Heritage’s parent company, Emcure, totaling approximately $96.5 million. The distribution plan aims to return millions of those dollars to consumers potentially harmed by the elevated prices.
“Hoosiers deserve fair pricing for their medications, and we will not tolerate illegal schemes that drive up costs and harm consumers,” Attorney General Rokita said. “We continue holding Big Pharma accountable when they harm Hoosiers by putting profits over people. I encourage anyone who purchased these generic drugs to see if they’re eligible for compensation.”
If you purchased a generic drug listed here between May 2009 and December 2019, you may be eligible for compensation. To determine your eligibility, call 1-866-290-0182 (toll-free), email info@AGGenericDrugs.com, or visit www.AGGenericDrugs.com.
Shelby County sees increased housing activity in October
Greensburg Mayor Joshua Marsh announces bid to retain office
Gov. Braun urges veterans to claim property tax relief before January deadline
Gas prices falling across Indiana
Shelby County Public Library renovation underway schedule changes begin next week
Former Indiana online charter schools director convicted of wire fraud and conspiracy in largest theft of public funds ever prosecuted in Southern District of Indiana
Muncie teen killed in Hancock County car-semi crash
SCPL seeks public input for strategic plan
